Invitae News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.17	Invitae to announce third quarter 2017 Financial Results and Host Conference Call on November 6, 2017 (PR Newswire)
17.10.17	Invitae data shows increased diagnosis rates with custom NGS technique allowing simultaneous genetic sequencing and copy number variant detection (PR Newswire)
05.10.17	Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide (PR Newswire)
13.09.17	Invitae highlighting new research, expanded suite of services at National Society of Genetic Counselors (NSGC) 36th Annual Conference (PR Newswire)
13.09.17	Invitae to Present at the Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
29.08.17	Invitae to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference (PR Newswire)
28.08.17	LendingClub To Hold 2017 Investor Day (PR Newswire)
07.08.17	Invitae Reports Second Quarter 2017 Results (PR Newswire)
02.08.17	TrackR Closes $50M Dollars In Series B Funding Led By Revolution Growth (PR Newswire)
31.07.17	Safeguard Scientifics Partner Company Good Start Genetics To Be Acquired By Invitae Corporation (PR Newswire)
31.07.17	Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life (PR Newswire)
31.07.17	Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth Opportunities and Reports Preliminary Second Quarter Financial Results (PR Newswire)
24.07.17	Invitae to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 7, 2017 (PR Newswire)
12.06.17	Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family History Analysis Platform (PR Newswire)
05.06.17	ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines (PR Newswire)
25.05.17	Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand (PR Newswire)
12.05.17	Invitae to Present at the UBS Global Healthcare Conference (PR Newswire)
08.05.17	Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017 (PR Newswire)
28.04.17	New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing (PR Newswire)
24.04.17	Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017 (PR Newswire)
20.04.17	Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses... (PR Newswire)
03.04.17	Invitae announces new partnership with Alnylam Pharmaceuticals to provide TTR gene testing for patients suspected of having hereditary ATTR amyloidosis (PR Newswire)
30.03.17	Invitae announces introduction of exome testing (PR Newswire)
23.03.17	Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults (PR Newswire)
22.03.17	Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting (PR Newswire)
14.03.17	Invitae to present seventeen posters and presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting (PR Newswire)
21.02.17	Invitae to present at the Cowen and Company 37th Annual Health Care Conference (PR Newswire)
17.02.17	New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment (PR Newswire)
13.02.17	Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017 (PR Newswire)
30.01.17	Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017 (PR Newswire)
19.01.17	Research Reports Initiation on Healthcare Stocks -- PAREXEL, Charles River Laboratories, PRA Health Sciences, and Invitae (PR Newswire)
09.01.17	Invitae announces new leadership structure to drive global growth (PR Newswire)
06.01.17	Invitae meets annual volume guidance, projects doubling of volume in 2017, accelerates Genome Network by acquiring scalable patient-centered data company (PR Newswire)
06.01.17	Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases (PR Newswire)
21.12.16	Invitae announces major expansion of its pediatric, neurological, and rare disease genetic test offerings (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Invitae Corp

Aktien Top/Flop

Meistgelesene Nachrichten